Total Payments
$596.13
2024 Payments
$25.68
Companies
9
Transactions
32
Medicare Patients
749
Medicare Billing
$70,252
Payment Breakdown by Category
Food & Beverage$505.01 (84.7%)
Education$91.12 (15.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $505.01 | 30 | 84.7% |
| Education | $91.12 | 2 | 15.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $193.90 | 11 | $0 (2022) |
| Janssen Biotech, Inc. | $163.80 | 5 | $0 (2024) |
| ABBVIE INC. | $87.28 | 6 | $0 (2022) |
| Allergan Inc. | $34.28 | 2 | $0 (2018) |
| Prometheus Laboratories Inc. | $32.08 | 2 | $0 (2017) |
| Braintree Laboratories, Inc. | $28.52 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $23.01 | 2 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.59 | 1 | $0 (2023) |
| PFIZER INC. | $10.67 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.68 | 1 | Janssen Biotech, Inc. ($25.68) |
| 2023 | $133.67 | 3 | Janssen Biotech, Inc. ($111.08) |
| 2022 | $90.05 | 5 | ABBVIE INC. ($53.00) |
| 2021 | $42.73 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($42.73) |
| 2020 | $63.79 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($49.35) |
| 2019 | $26.69 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($15.78) |
| 2018 | $119.33 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($48.99) |
| 2017 | $94.19 | 7 | Prometheus Laboratories Inc. ($32.08) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Immunology | ||||||
| 05/17/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $76.00 | General |
| Category: Immunology | ||||||
| 04/25/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $35.08 | General |
| Category: Immunology | ||||||
| 02/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/08/2022 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Gastroenterology | ||||||
| 08/31/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Gastroenterology | ||||||
| 06/22/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: IMMUNOLOGY | ||||||
| 04/20/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: IMMUNOLOGY | ||||||
| 06/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Gastroenterology | ||||||
| 05/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Gastroenterology | ||||||
| 12/21/2020 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: GI COLON PREP | ||||||
| 03/25/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/25/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/10/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/09/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/22/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Virology | ||||||
| 12/11/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2018 | Braintree Laboratories, Inc. | SUPREP (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/29/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | UCERIS (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/31/2018 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $11.37 | General |
| 04/17/2018 | Janssen Biotech, Inc. | STELARA (Biological), SIMPONI | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Immunology | ||||||
| 03/01/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/18/2018 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: INFLAMMATION | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 211 | 234 | $101,765 | $16,594 |
| 2020 | 11 | 538 | 571 | $319,192 | $53,658 |
Total Patients
749
Total Services
805
Medicare Billing
$70,252
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 104 | 127 | $12,700 | $6,090 | 48.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 42 | 42 | $45,636 | $4,280 | 9.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 14 | 14 | $15,960 | $2,642 | 16.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 25 | 25 | $3,750 | $1,816 | 48.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 26 | 26 | $23,719 | $1,765 | 7.4% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 84 | 84 | $81,993 | $9,914 | 12.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 45 | 45 | $46,424 | $8,992 | 19.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 102 | 123 | $12,218 | $7,241 | 59.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 35 | 35 | $29,394 | $6,274 | 21.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 76 | 85 | $15,757 | $4,271 | 27.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 56 | 57 | $48,745 | $3,886 | 8.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 39 | 40 | $5,938 | $3,543 | 59.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 42 | 42 | $10,960 | $2,950 | 26.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 16 | 16 | $13,442 | $2,929 | 21.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 27 | $6,775 | $1,937 | 28.6% |
| 43249 | Balloon dilation of esophagus using an endoscope | Facility | 2020 | 16 | 17 | $47,546 | $1,721 | 3.6% |
About Dr. Jeffrey Jones, M.D
Dr. Jeffrey Jones, M.D is a Internal Medicine healthcare provider based in Colfax, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639159882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Jones, M.D has received a total of $596.13 in payments from pharmaceutical and medical device companies, with $25.68 received in 2024. These payments were reported across 32 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($505.01).
As a Medicare-enrolled provider, Jones has provided services to 749 Medicare beneficiaries, totaling 805 services with total Medicare billing of $70,252. Data is available for 2 years (2020–2021), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Colfax, WA
- Active Since 01/21/2006
- Last Updated 06/26/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1639159882
Products in Payments
- STELARA (Biological) $138.12
- TRULANCE (Drug) $129.13
- XIFAXAN (Drug) $53.38
- SKYRIZI (Biological) $35.57
- TREMFYA (Drug) $25.68
- FARXIGA (Drug) $23.01
- Mavyret (Drug) $22.91
- ENTYVIO (Biological) $22.59
- DALVANCE (Drug) $20.56
- RINVOQ (Biological) $17.43
- SUTAB (Drug) $14.44
- SUPREP (Drug) $14.08
- LINZESS (Drug) $13.72
- UCERIS (Drug) $11.39
- INFLECTRA (Biological) $10.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.